FLT3 and acute myeloid leukemia: In view of the hypothesis that CSL cells contribute to AML relapse and our finding that SORE6+ cells have CSL properties, we attempted to establish an in vitro model to study AML relapse by using a mixture of SORE6−/SORE6+ cells derived from the two FLT3-mutated AML cell lines.